Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

Tysinor 150 Mg Capecitabine USP

Capecitabine

5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect

Capecitabine, DNA, RNA and Protein Synthesis Inhibitors

Cell Cycle Inhibitor Immunology Reagents - Creative Diagnostics

Gemcitabine (LY 188011), DNA Synthesis Inhibitor

POR Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer

Mechanism of Action (MOA) Vistogard®(uridine triacetate) oral granules

Biomedicines, Free Full-Text

Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes

DNA and RNA Synthesis: Antifolates